Robert R Luedtke

发表

Subtype Selectivity of Dopamine Receptor Ligands: Insights from Structure and Ligand-Based Methods

Qi Wang, Robert H Mach, Robert R Luedtke, 2010, J. Chem. Inf. Model..

N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.

Robert R Luedtke, Amy Hauck Newman, D. Sibley, 2011, Journal of medicinal chemistry.

Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol.

Noel M. Paul, Robert R Luedtke, Michelle Taylor, 2008, Journal of medicinal chemistry.

Synthesis and characterization of selective dopamine D2 receptor antagonists.

Robert H Mach, Robert R Luedtke, Jinbin Xu, 2006, Bioorganic & medicinal chemistry.

Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.

Robert R Luedtke, Peter Grundt, Michelle Taylor, 2007, Bioorganic & medicinal chemistry letters.

Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.

Ji-Kyung Choi, Robert R Luedtke, Peter Grundt, 2007, Journal of medicinal chemistry.

RGS9 Modulates Dopamine Signaling in the Basal Ganglia

Johannes Schwarz, David Self, Robert R Luedtke, 2003, Neuron.

N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.

Robert R Luedtke, Peter Grundt, Michelle Taylor, 2009, Journal of medicinal chemistry.

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.

Erin E. Carlson, Erin E Carlson, Robert R Luedtke, 2005, Journal of medicinal chemistry.

Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.

Robert H Mach, Robert R Luedtke, David E Reichert, 2012, ACS chemical neuroscience.

Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

Robert H Mach, Robert R Luedtke, Jinbin Xu, 2005, Bioorganic & medicinal chemistry.

Quantitative Changes in Gαolf Protein Levels, but not D1 Receptor, Alter Specifically Acute Responses to Psychostimulants

Denis Hervé, Jean-Antoine Girault, Leonardo Belluscio, 2007, Neuropsychopharmacology.